For the quarter ending 2025-09-30, XPOF had $2,784K increase in cash & cash equivalents over the period. $8,221K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash and cash equivalents at beginning of period | 32,739 | - |
| Gain on disposal of assets | - | 931 |
| Net loss | -6,746 | -1,313 |
| Depreciation and amortization | 3,679 | 5,929 |
| Amortization and write off of debt issuance cost | 36 | 87 |
| Amortization and write off of discount on long-term debt | 2,331 | 3,664 |
| Change in contingent consideration from acquisitions | -3,071 | 10,553 |
| Non-cash lease expense | 966 | 2,207 |
| Change in tax receivable agreement liability | 644 | -1,975 |
| Bad debt expense | 1,623 | 1,163 |
| Equity-based compensation | 2,394 | 5,947 |
| Non-cash interest | -805 | -747 |
| Gain on disposal of assets and lease terminations | 5,021 | - |
| Gain on divestitures | 4,866 | - |
| Impairment of goodwill and other noncurrent assets | 17,568 | 14,843 |
| Accounts receivable | -16,466 | 11,949 |
| Inventories | -1,731 | -2,624 |
| Prepaid expenses and other current assets | 8,198 | 4,146 |
| Operating lease liabilities | -838 | -1,934 |
| Deferred costs | -4,081 | -2,065 |
| Notes receivable, net | -2 | -1 |
| Accounts payable | -6,728 | -4,662 |
| Accrued expenses | -10,133 | 12,127 |
| Other current liabilities | -1,420 | -2,417 |
| Deferred revenue | -10,202 | -7,335 |
| Other assets | -251 | -1,296 |
| Other liabilities | 9,770 | 400 |
| Net cash provided by operating activities | 9,299 | 8,341 |
| Purchases of property and equipment | 1,078 | 1,992 |
| Proceeds from sale of assets | 0 | 0 |
| Purchase of intangible assets | 421 | 803 |
| Notes receivable issued | 0 | 173 |
| Notes receivable payments received | 61 | 108 |
| Proceeds from disposition of brands | 2,000 | - |
| Acquisition of business | 0 | 0 |
| Net cash used in investing activities | 562 | -2,860 |
| Borrowings from long-term debt | 0 | 10,000 |
| Payments on long-term debt | 1,375 | 2,748 |
| Debt issuance costs | 0 | 90 |
| Payment of preferred stock dividend | 5,694 | - |
| Payment of promissory note liability | 3,392 | - |
| Payments of contingent consideration | 0 | 500 |
| Payments for taxes related to net share settlement of restricted share units | 199 | 2,097 |
| Payment of preferred stock dividend and deemed cash dividend | - | 3,796 |
| Proceeds from issuance of common stock in connection with stock-based compensation plans | 0 | 122 |
| Payments for tax receivable agreement | 0 | 0 |
| Payments for distributions to pre-ipo llc members | 51 | 432 |
| Payment received from shareholder (note 10) | 0 | 0 |
| Reimbursement from shareholder (note 10) | 162 | - |
| Net cash provided by (used in) financing activities | -7,077 | 459 |
| Increase in cash, cash equivalents and restricted cash | 2,784 | 5,940 |
| Cash and cash equivalents at end of period | 41,463 | - |
Xponential Fitness, Inc. (XPOF)
Xponential Fitness, Inc. (XPOF)